Newsroom
For media inquiries, please contact 340B Health Senior VP of Communications Richard Sorian at richard.sorian@340bhealth.org or 202-536-2285.
-
340B HEALTH BOARD ELECTS THREE NEW MEMBERS
-
FIVE HOSPITAL ASSOCIATIONS URGE APPEALS COURTS TO BACK 340B ENFORCEMENT
-
FINANCIAL LOSSES FROM DRUG COMPANIES’ 340B RESTRICTIONS HAVE MORE THAN DOUBLED SINCE THE END OF 2021
-
STATEMENT ON GOVERNMENT APPEAL OF COURT DECISION IN ASTRAZENECA 340B CONTRACT PHARMACY LAWSUIT
-
STUDY DEMONSTRATES ESSENTIAL ROLE OF 340B AMID COVID-19 CHALLENGES AND DRUG COMPANY RESTRICTIONS
-
BOEHRINGER INGELHEIM REFERRED FOR PENALTIES FOR CONTINUED VIOLATIONS OF FEDERAL LAW ON 340B PRICING
-
Hospital groups worry as more drugmakers limit 340B discounts
-
STATEMENT ON JOHNSON & JOHNSON RESTRICTING 340B DISCOUNTS
-
STATEMENT ON GILEAD RESTRICTING 340B DISCOUNTS THROUGH COMMUNITY-BASED PHARMACIES
-
STATEMENT ON APPROVAL OF 340B ELIGIBILITY PROTECTIONS FOR SAFETY-NET HOSPITALS ON THE COVID FRONT LINES
-
STATEMENT ON NEW DIRECTOR OF HRSA OFFICE OF PHARMACY AFFAIRS
-
STATEMENT ON FEDERAL COURT DECISION IN ASTRAZENECA’S 340B COMMUNITY PHARMACY LAWSUIT